Treatment and outcome of Shiga-toxin-associated hemolytic uremic syndrome (HUS). (Q33380757)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18704506 AND SRC:MED&resulttype=core&format=json

12 January 2020

review article

1 reference

title

Treatment and outcome of Shiga-toxin-associated hemolytic uremic syndrome (HUS) (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18704506 AND SRC:MED&resulttype=core&format=json

hemolytic-uremic syndrome

12 January 2020

main subject

1 reference

PubMed publication ID

18704506

Shiga toxin

1 reference

PubMed publication ID

2

Sharon P Andreoli

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18704506 AND SRC:MED&resulttype=core&format=json

12 January 2020

author name string

Johanna Scheiring

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18704506 AND SRC:MED&resulttype=core&format=json

12 January 2020

Lothar Bernd Zimmerhackl

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18704506 AND SRC:MED&resulttype=core&format=json

12 January 2020

publication date

13 August 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18704506 AND SRC:MED&resulttype=core&format=json

12 January 2020

1 October 2008

0 references

published in

Pediatric Nephrology

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18704506 AND SRC:MED&resulttype=core&format=json

12 January 2020

29 May 2020

23

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18704506 AND SRC:MED&resulttype=core&format=json

12 January 2020

issue

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18704506 AND SRC:MED&resulttype=core&format=json

12 January 2020

page(s)

1749-1760

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18704506 AND SRC:MED&resulttype=core&format=json

Creative Commons Attribution 4.0 International

12 January 2020

copyright license

0 references

copyright status

copyrighted

0 references

cites work

A classification of hemolytic uremic syndrome and thrombotic thrombocytopenic purpura and related disorders

1 reference

https://api.crossref.org/works/10.1007/S00467-008-0935-6

The association between idiopathic hemolytic uremic syndrome and infection by verotoxin-producing Escherichia coli

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00467-008-0935-6

Targeting of Shiga toxin B-subunit to retrograde transport route in association with detergent-resistant membranes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00467-008-0935-6

A Nationwide Case-Control Study of Escherichia coli O157:H7 Infection in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00467-008-0935-6

Blood pressure in the long-term follow-up of children with hemolytic uremic syndrome

21 January 2018

1 reference

12 December 2020

Hemolytic-uremic syndrome: bilateral necrosis of the renal cortex in acute acquired hemolytic anemia

1 reference

12 December 2020

New aspects in the pathogenesis of enteropathic hemolytic uremic syndrome

1 reference

12 December 2020

Shiga toxin activatable by intestinal mucus in Escherichia coli isolated from humans: predictor for a severe clinical outcome.

1 reference

12 December 2020

Elastase in intestinal mucus enhances the cytotoxicity of Shiga toxin type 2d

1 reference

12 December 2020

Transduction of enteric Escherichia coli isolates with a derivative of Shiga toxin 2-encoding bacteriophage phi3538 isolated from Escherichia coli O157:H7.

1 reference

12 December 2020

Shiga toxin-producing Escherichia coli in Montana: bacterial genotypes and clinical profiles

1 reference

12 December 2020

Clinical course and the role of shiga toxin-producing Escherichia coli infection in the hemolytic-uremic syndrome in pediatric patients, 1997-2000, in Germany and Austria: a prospective study

1 reference

12 December 2020

Shiga-toxin-producing Escherichia coli and haemolytic uraemic syndrome

1 reference

12 December 2020

Assessment in mice of the therapeutic potential of tailored, multivalent Shiga toxin carbohydrate ligands

1 reference

12 December 2020

Activation of Shiga-like toxins by mouse and human intestinal mucus correlates with virulence of enterohemorrhagic Escherichia coli O91:H21 isolates in orally infected, streptomycin-treated mice

1 reference

12 December 2020

Cytolethal distending toxin in Escherichia coli O157:H7: spectrum of conservation, structure, and endothelial toxicity

1 reference

12 December 2020

Effect of an oral Shiga toxin-binding agent on diarrhea-associated hemolytic uremic syndrome in children: a randomized controlled trial

1 reference

12 December 2020

Escherichia coli harboring Shiga toxin 2 gene variants: frequency and association with clinical symptoms

1 reference

12 December 2020

Application of combined high-performance thin-layer chromatography immunostaining and nanoelectrospray ionization quadrupole time-of-flight tandem mass spectrometry to the structural characterization of high- and low-affinity binding ligands of Shig

1 reference

12 December 2020

Thrombotic microangiopathy, hemolytic uremic syndrome, and thrombotic thrombocytopenic purpura

1 reference

12 December 2020

Spectrum of extrarenal involvement in postdiarrheal hemolytic-uremic syndrome

1 reference

12 December 2020

Epidemiology, pathogenesis and therapeutic modalities in hemolytic-uremic syndrome

1 reference

12 December 2020

Epidemic hemolytic-uremic syndrome in children

1 reference

12 December 2020

1 reference

12 December 2020

Hemolytic uremic syndrome: epidemiology, pathophysiology, and therapy

1 reference

12 December 2020

Function of von Willebrand factor in children with diarrhea-associated hemolytic-uremic syndrome (D HUS).

1 reference

12 December 2020

Prothrombotic coagulation abnormalities preceding the hemolytic-uremic syndrome

1 reference

12 December 2020

Characterization of cytolethal distending toxin genes and expression in shiga toxin-producing Escherichia coli strains of non-O157 serogroups

1 reference

12 December 2020

Thrombotic thrombocytopenic purpura associated with Shiga toxins.

1 reference

12 December 2020

Genetic studies into inherited and sporadic hemolytic uremic syndrome

1 reference

12 December 2020

Stx-phages: drivers and mediators of the evolution of STEC and STEC-like pathogens

1 reference

12 December 2020

Escherichia coli O157:H7 strains associated with haemorrhagic colitis in the United States produce a Shigella dysenteriae 1 (SHIGA) like cytotoxin

1 reference

12 December 2020

Enterohemorrhagic Escherichia coli in human infection: in vivo evolution of a bacterial pathogen

1 reference

12 December 2020

Recycling of Shiga toxin 2 genes in sorbitol-fermenting enterohemorrhagic Escherichia coli O157:NM

1 reference

12 December 2020

Shiga toxins even when different are encoded at identical positions in the genomes of related temperate bacteriophages

1 reference

12 December 2020

Plasma infusion for hemolytic-uremic syndrome in children: results of a multicenter controlled trial

1 reference

12 December 2020

Pathogenesis and diagnosis of Shiga toxin-producing Escherichia coli infections

1 reference

12 December 2020

Long-term (15-25 years) outcome of childhood hemolytic-uremic syndrome.

1 reference

12 December 2020

Antibody therapy in the management of shiga toxin-induced hemolytic uremic syndrome

1 reference

12 December 2020

Phenotypic and genotypic analyses of enterohemorrhagic Escherichia coli O145 strains from patients in Germany

1 reference

12 December 2020

Transcriptional analysis of genes encoding Shiga toxin 2 and its variants in Escherichia coli

1 reference

12 December 2020

Subtypes of the plasmid-encoded serine protease EspP in Shiga toxin-producing Escherichia coli: distribution, secretion, and proteolytic activity

1 reference

12 December 2020

Risk of hemolytic uremic syndrome after sporadic Escherichia coli O157:H7 infection: results of a Canadian collaborative study. Investigators of the Canadian Pediatric Kidney Disease Research Center

1 reference

12 December 2020

Haemolytic-uraemic syndrome outbreak caused by Escherichia coli O111:H-: clinical outcomes

1 reference

12 December 2020

Activation of Shiga toxin type 2d (Stx2d) by elastase involves cleavage of the C-terminal two amino acids of the A2 peptide in the context of the appropriate B pentamer

1 reference

12 December 2020

Structural and functional differences between disease-associated genes of enterohaemorrhagic Escherichia coli O111.

1 reference

12 December 2020

Identification of new verocytotoxin type 2 variant B-subunit genes in human and animal Escherichia coli isolates

1 reference

12 December 2020

Epidemiology, clinical presentation, and pathophysiology of atypical and recurrent hemolytic uremic syndrome

1 reference

12 December 2020

E. coli, antibiotics, and the hemolytic-uremic syndrome

1 reference

12 December 2020

Identification, characterization, and distribution of a Shiga toxin 1 gene variant (stx(1c)) in Escherichia coli strains isolated from humans

1 reference

12 December 2020

Human neutrophils and their products induce Shiga toxin production by enterohemorrhagic Escherichia coli

1 reference

12 December 2020

Shiga toxin 1c-producing Escherichia coli strains: phenotypic and genetic characterization and association with human disease

1 reference

12 December 2020

The role of plasma exchange in the treatment of severe forms of hemolytic-uremic syndrome in childhood

1 reference

12 December 2020

Quinolone antibiotics induce Shiga toxin-encoding bacteriophages, toxin production, and death in mice.

1 reference

12 December 2020

The risk of recurrence of hemolytic uremic syndrome after renal transplantation in children

1 reference

12 December 2020

Renal transplantation in HUS patients with disorders of complement regulation

1 reference

12 December 2020

The complement inhibitor eculizumab in paroxysmal nocturnal hemoglobinuria

1 reference

12 December 2020

Molecular profiling and phenotype analysis of Escherichia coli O26:H11 and O26:NM: secular and geographic consistency of enterohemorrhagic and enteropathogenic isolates

1 reference

12 December 2020

Shiga toxin-mediated hemolytic uremic syndrome: time to change the diagnostic paradigm?

1 reference

12 December 2020

The histopathology of the hemolytic uremic syndrome associated with verocytotoxin-producing Escherichia coli infections.

1 reference

12 December 2020

Enterohemorrhagic Escherichia coli (EHEC) in pediatric hemolytic-uremic syndrome: a prospective study in Germany and Austria.

1 reference

12 December 2020

Pigeons as a possible reservoir of Shiga toxin 2f-producing Escherichia coli pathogenic to humans

1 reference

12 December 2020

Hemolytic uremic syndrome; pathogenesis, treatment, and outcome

1 reference

12 December 2020

Chromosomal dynamism in progeny of outbreak-related sorbitol-fermenting enterohemorrhagic Escherichia coli O157:NM.

1 reference

12 December 2020

Efficient endosome-to-Golgi transport of Shiga toxin is dependent on dynamin and clathrin

1 reference

12 December 2020

Development of insulin-dependent diabetes mellitus during the hemolytic-uremic syndrome

1 reference

12 December 2020

Role of the renin angiotensin system in TNF-alpha and Shiga-toxin-induced tissue factor expression

1 reference

12 December 2020

Thrombotic microangiopathic haemolytic anaemia (thrombotic microangiopathy)

1 reference

12 December 2020

Troponin I levels in a hemolytic uremic syndrome patient with severe cardiac failure

1 reference

12 December 2020

Molecular and phenotypic profiling of sorbitol-fermenting Escherichia coli O157:H- human isolates from Finland

1 reference

12 December 2020

Enterohemorrhagic Escherichia coli infections: following transmission routes

1 reference

12 December 2020

Risk of hemolytic uremic syndrome after antibiotic treatment of Escherichia coli O157:H7 enteritis: a meta-analysis

1 reference

12 December 2020

The Shiga toxin genotype rather than the amount of Shiga toxin or the cytotoxicity of Shiga toxin in vitro correlates with the appearance of the hemolytic uremic syndrome

1 reference

12 December 2020

Immune response to Escherichia coli O157:H7 in hemolytic uremic syndrome following salmonellosis

1 reference

12 December 2020

Shiga toxin 2e-producing Escherichia coli isolates from humans and pigs differ in their virulence profiles and interactions with intestinal epithelial cells

1 reference

12 December 2020

A rapid method for the discrimination of genes encoding classical Shiga toxin (Stx) 1 and its variants, Stx1c and Stx1d, in Escherichia coli.

1 reference

12 December 2020

The risk of the hemolytic-uremic syndrome after antibiotic treatment of Escherichia coli O157:H7 infections

1 reference

12 December 2020

Long-term outcome and prognostic indicators in the hemolytic-uremic syndrome

1 reference

12 December 2020

Bacteriophage control of bacterial virulence

1 reference

12 December 2020

Enhancement of Shiga toxin production in enterohemorrhagic Escherichia coli serotype O157:H7 by DNase colicins

1 reference

12 December 2020

Relative nephroprotection during Escherichia coli O157:H7 infections: association with intravenous volume expansion

1 reference

12 December 2020

Hemolysin from Shiga toxin-negative Escherichia coli O26 strains injures microvascular endothelium

1 reference

12 December 2020

Induction of prophages of enterohemorrhagic Escherichia coli O157:H7 with norfloxacin

1 reference

12 December 2020

Cytolethal distending toxin from Shiga toxin-producing Escherichia coli O157 causes irreversible G2/M arrest, inhibition of proliferation, and death of human endothelial cells

1 reference

12 December 2020

Shiga toxin gene loss and transfer in vitro and in vivo during enterohemorrhagic Escherichia coli O26 infection in humans

1 reference

12 December 2020

Long-term renal prognosis of diarrhea-associated hemolytic uremic syndrome: a systematic review, meta-analysis, and meta-regression

1 reference

12 December 2020

Colonic stenosis after hemolytic-uremic syndrome

1 reference

12 December 2020

Molecular Analysis of Shiga Toxigenic Escherichia coli O111:H − Proteins Which React with Sera from Patients with Hemolytic-Uremic Syndrome

1 reference

12 December 2020

Colonic stricture secondary to hemolytic uremic syndrome caused by Escherichia coli O-157.

1 reference

12 December 2020

10.1007/S00467-008-0935-6

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18704506 AND SRC:MED&resulttype=core&format=json

Dimensions Publication ID

12 January 2020

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18704506 AND SRC:MED&resulttype=core&format=json

12 January 2020

PubMed publication ID

18704506

1 reference